Navigation Links
Eisai Launches New Website Providing Employers with Educational Resource for Obesity Management
Date:8/15/2013

WOODCLIFF LAKE, N.J., Aug. 15, 2013 /PRNewswire/ -- Eisai Inc. announced today the launch of a new website to provide employers with an educational resource for information about obesity management. The website, "Closing the Gap: Obesity Management for Employers," can be accessed at http://ctgobesity.com/.

"We know from our research that most employers consider obesity to be a top employee health challenge," said Dave Martin, Vice President of Managed Markets, Value and Access for Eisai.  "While there are some helpful resources available for employers, we also noted significant gaps; therefore, we decided to build this all-inclusive website as a companion to an e-newsletter, in partnership with The Benfield Group."

Both the e-newsletter and the website will provide employers access to articles, links to other sites and other downloadable tools including:Closing the Gap in Obesity Management Solutions: The Importance of Integrating New Prescription Medications into Employer Strategies to Help Reduce Obesity in their Employee and Dependent Populations. A publication that reviews the challenges and opportunities of obesity management and provides recommendations from an Eisai-sponsored advisory board of leading employer health benefit decision-makers on approaches to update employer strategies.

Blueprint for Health™: A free, interactive online tool available through the American College of Occupational and Environmental Medicine (ACOEM) that allows employers to estimate direct and indirect costs associated with the conditions they select, by entering key employee demographics.

Your Weight Matters(SM) Campaign (YWM): The Your Weight Matters Campaign was developed by the Obesity Action Coalition (OAC) and sponsored by Eisai. The Your Weight Matters Campaign encourages all Americans to measure their weight and take the Campaign Challenge by making a pledge to talk to a healthcare provider about their weight and its impact on their health. All Campaign participants receive a FREE toolkit to help them prepare for the conversation of weight with their healthcare provider.

The content for the Blueprint for Health and Your Weight Matters Campaign websites are not controlled by Eisai.

Eisai Inc.At Eisai Inc., human health care is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to help address unmet medical needs. We are a fully integrated pharmaceutical business with discovery, clinical, manufacturing and marketing capabilities. Our key areas of commercial focus include oncology and specialty care (Alzheimer's disease, epilepsy and metabolic disorders). To learn more about Eisai Inc., please visit us at www.eisai.com/US

Eisai Inc. has affiliates that are part of a global product creation organization that includes R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as well as a global demand chain organization that includes manufacturing facilities in Maryland and North Carolina. Eisai's global areas of R&D focus include neuroscience; oncology; metabolic disorders; vascular, inflammatory and immunological reaction; and antibody-based programs. Media Inquiries  Investor InquiriesMarcia Diljak

Alex ScottEisai Inc.

Eisai Inc.(201) 746-2236 

(201) 746-2177


'/>"/>
SOURCE Eisai Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
2. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
3. Eisai USA Foundation to Donate $1 Million to the Conquer Cancer Foundation of the American Society of Clinical Oncology
4. Eisai To Sponsor 7th Annual National Walk For Epilepsy To Help Raise Epilepsy Awareness
5. Lynn Kramer, MD, Appointed Chief Clinical Officer of Eisai Product Creation Systems
6. FDA Grants Orphan Drug Status To Eisais Lenvatinib
7. Eisai Oncology to Present New Research on Eribulin at 35th Annual San Antonio Breast Cancer Symposium
8. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
9. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
10. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
11. Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... --   , Study met ... cleansing and superiority in , Excellent ... of the ascending colon   , ... Norgine B.V. today announced new positive data from the phase III ... versus standard 2 litre PEG with ascorbate. The study met both ...
(Date:5/24/2016)... Zealand , May 24, 2016 ... informatics solutions for the healthcare sector, has been named the ... Zealand Hi-Tech Awards 2016. Dr Bruce Davey ... acknowledgement for our team.  It,s really good to be recognised ... healthcare internationally. Our products are used in 35 countries around ...
(Date:5/24/2016)... , May 24, 2016 Celsion ... drug development company, today provided an update on ... escalating clinical trial combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  GEN-1 is an IL-12 DNA plasmid ...
Breaking Medicine Technology:
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Southland ... line of classic American timber frame barn kits, which can be found on its ... inspired by historic American barn plans, and they highlight the craftsmanship of timber post ...
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of acute stroke survivors ... sustainable product to aid in the rehabilitation process has steadily increased. Ekso Bionics had ... with hemiplegia due to stroke. , Ekso Bionics has now received clearance from the ...
(Date:5/27/2016)... ... May 27, 2016 , ... Beleza Medspa has initiated a new ... This is the first time that Coolsculpting is being used for for more than ... to ensure they meet the prescribed body-fat standard, measured by the circumference-based tape method. ...
(Date:5/27/2016)... ... May 27, 2016 , ... With a team of ... food industries. Aside from its GMP accreditation, Validation Center is also a registered ... products, services and staff. , Validation Center is ISO17025 accredited and only offers ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
Breaking Medicine News(10 mins):